Related Experiment Video
Updated: Sep 19, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
NK cell activity in the tumor microenvironment
A V Kuznetsova1,2, X A Glukhova3, I P Beletsky3
1Laboratory of Molecular and Cellular Pathology, Russian University of Medicine, Ministry of Health of the Russian Federation, Moscow, Russia.
Abstract:
The formation of an immunosuppressive tumor microenvironment (TME) impairs natural killer (NK) cell infiltration and persistence within tumor tissue and significantly diminishes NK-mediated cytotoxicity. This presents a substantial barrier to the efficacy of NK cell therapy in solid tumors. Current strategies aim to overcome immune evasion by enhancing NK cell recognition and cytotoxicity, while promoting their persistence, infiltration, and resistance to the TME. This review focusses on the biophysical characteristics of TME and specific components of the extracellular matrix (ECM) that affect NK cell activity, with the goal of identifying therapeutic approaches to modulate the TME and create a supportive niche for adaptive immune cell function. Advancements in interdisciplinary collaborations integrating oncology, cell biology, physics, engineering, materials science, and nanotechnology are crucial in advancing therapeutic strategies targeting ECM rigidity and mechanotransduction signaling pathways.
Insights
The tumor microenvironment (TME) suppresses natural killer (NK) cell therapy. Modulating the extracellular matrix (ECM) in the TME can improve NK cell function and enhance cancer immunotherapy efficacy.
Area of Science:
- Immunology
- Oncology
- Biophysics
- Materials Science
- Nanotechnology
Background:
- The tumor microenvironment (TME) creates an immunosuppressive state that hinders natural killer (NK) cell infiltration, persistence, and cytotoxic activity, limiting the effectiveness of NK cell-based cancer immunotherapies, particularly in solid tumors.
- Current therapeutic strategies focus on overcoming tumor immune evasion by boosting NK cell recognition, cytotoxicity, and resistance to the TME, alongside enhancing their infiltration and persistence.
Purpose of the Study:
- This review examines the biophysical properties of the TME and extracellular matrix (ECM) components that impact NK cell function.
- The study aims to identify therapeutic strategies for modulating the TME to establish a more supportive environment for adaptive immune cell activity.
Main Methods:
- Review of existing literature on the TME, ECM, NK cell biology, and cancer immunotherapy.
- Analysis of biophysical characteristics of the TME and their influence on NK cell function.
- Exploration of interdisciplinary approaches involving oncology, cell biology, physics, engineering, materials science, and nanotechnology.
Main Results:
- The TME's biophysical characteristics, including ECM rigidity, significantly impede NK cell-mediated anti-tumor responses.
- Specific ECM components and mechanotransduction signaling pathways within the TME play critical roles in regulating NK cell activity.
- Interdisciplinary research is essential for developing novel therapeutic interventions.
Conclusions:
- Targeting the biophysical properties of the TME, particularly ECM rigidity and associated signaling pathways, holds promise for enhancing NK cell therapy efficacy.
- Creating a permissive TME through targeted interventions can improve NK cell infiltration, persistence, and cytotoxic function, thereby advancing cancer immunotherapy.
- Collaborative efforts across multiple scientific disciplines are vital for translating these findings into effective clinical strategies.
Related Concept Videos
The Tumor Microenvironment
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Tumor Immunotherapy

